Steven Nichtberger, MD, chairman and CEO of ControlRad Systems, Inc. and adjunct professor of health care management at the University of Pennsylvania’s Wharton School, has been appointed to the Main Line Health Board of Governors effective July 1, 2014. Dr. Nichtberger has spent the last 20 years focused on developing and commercializing breakthrough medical advances. In his current role as chairman of ControlRad Systems, Inc., Dr. Nichtberger leads the organization’s development and commercialization of products to dramatically reduce the dose and risk associated with medical radiation required for diagnostic and interventional procedures.
Dr. Nichtberger’s broad experience as past head of Marketing at Merck and subsequently as a serial entrepreneur, spans global pharmaceuticals, biotechnology, and devices across commercial and scientific domains. As a senior fellow and adjunct professor at Penn, Dr. Nichtberger leads the Vagelos Life Sciences & Management capstone course on health care company formation, financing and leadership. Dr. Nichtberger also serves as Managing Partner of GBF, providing advisory services to health care companies, investors and leading academic scientists to maximize the value of breakthrough advances.
“I am pleased to welcome Steven to the board,” George W. Gephart, Jr., board chair said. “Steven’s keen interest in advancing human health and well being supports Main Line Health’s mission, and his insights and expertise will add depth to our research mission.”
“We are honored to have Steven join our Board of Governors and believe that his business acumen combined with his extraordinary commitment to the field of life sciences will make him an asset to our organization,” said Jack Lynch, president and CEO of Main Line Health. “He is a visionary leader in the health care field and we are confident that his considerable talents will equip him to successfully fulfill his responsibilities as a Trustee of the Main Line Health Board of Governors.”
Dr. Nichtberger is a long time member of the Board of Overseers of the School of Arts & Sciences at the University of Pennsylvania as well as a member of the Board of Directors of BioAdvance, the biotechnology greenhouse for southeastern Pennsylvania. Selected past board memberships include the national BIO Association Board as well as the PA BIO board, where he was chairman. Dr. Nichtberger holds a BS in Economics from the Wharton School and a BA in Biology from the School of Arts & Sciences, both at the University of Pennsylvania. He earned his MD from the School of Medicine and Biosciences, SUNY at Buffalo. He is also a board certified internist and cardiologist trained at Mount Sinai Medical Center, in New York.
Steven and his family reside in Villanova, Pennsylvania.